AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases

Presentations at the 2026 meeting of the American Academy of Dermatology not only demonstrate the therapeutic potential of next-generation skin drugs but also shed light on how they might fare on the market.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top